N-acetylcysteine reduces disease activity by blocking mTOR in T cells of lupus patients
Arthritis & Rheumatism, 05/11/2012
Lai ZW et al. – This pilot study suggests that N–acetylcysteine (NAC) safely improves lupus disease activity by blocking mTOR in T lymphocytes.



